3-Fluoro-5-(hydroxymethyl)phenol, 98%, 500mg

N-ethyl-2-methylbenzenesulfonamide, 98%, 1g

5-Acetyl-3-chloro-10,11-dihydrodibenzo[b,f]azepine>98.0%(GC)(N)25g

(2-Aminoethyl)-benzyl carbamic acid tert-butylester, 98.0%, 1g

6-Chloro-2-methoxynicotinaldehyde, 95.0%, 100g

Ethyl 5-bromothiophene-3-carboxylate, 95.0%, 5g

2-(2,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

1,4-Bis[2-(5-phenyloxazolyl)]benzene min 99% for scintillation 5 g

Plan PLMi 10x/0.25 infinity corrected IOS objective. Working distance 20.2 mm

2,6-Dichloro-N-phenylaniline, 95.0%, 25g

Ethyl 8-hydroxy-2-methylimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 1g

N-(2-Fluoro-phenyl)-malonamic acid ethyl ester, 95.0%, 1g

Fluocinolone, 10mg